PPARG and type 2 diabetes mellitus: TZDs, such as pioglitazone and rosiglitazone, are synthetic ligands of peroxisome proliferator-activated receptors gamma (PPARγ) used in therapeutic treatments for patients diagnosed with type II diabetes mellitus [12, 13].